Desde SEIOMM/FEIOMM en colaboración con AMGEN y Ferrer os presentamos:
Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2018 Feb;29(2):265-286. doi: 10.1007/s00198-017-4339-y. Epub 2018 Jan 6. Varahra A, Rodrigues IB, MacDermid JC, Bryant D, Birmingham T.
TNFα blockade mediates bone protection in antigen-induced arthritis by reducing osteoclast precursor supply.
Bone. 2018 Feb; 107:56-65 Uster S, Matos Coelho F, Aeberli D, Stein JV, Hofstetter W, Engelhardt R, Seitz M.
Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
Osteoporos Int. 2018 Feb;29(2):501-506. doi: 10.1007/s00198-017-4286-7. Epub 2017 Oct 30. Greenspan SL, Vujevich K, Britton C, Herradura A, Gruen G, Tarkin I, Siska P, Hamlin B, Perera S.
Bone-Targeted Therapies in Cancer-Induced Bone Disease.
Calcif Tissue Int 2018 2018 Feb;102(2):227-250. doi: 10.1007/s00223-017-0353-5. Epub 2017 Oct 27. Sousa S, Clézardin P
Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study.
J Bone Miner Res. 2018 Feb;33(2):298-306. Dempster DW, Zhou H, Recker RR, Brown JP, Recknor CP, Lewiecki EM, Miller PD, Rao SD, Kendler DL, Lindsay R, Krege JH, Alam J, Taylor KA, Melby TE, Ruff … Leer más
Osteoporosis in chronic liver disease
Liver Int. 2018 Feb 26. doi: 10.1111/liv.13730 Guañabens N, Parés A
Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project
Blood Cells Mol Dis. 2018 Feb;68:173-179. doi:10.1016/j.bcmd.2016.10.017 Giraldo P, Andrade-Campos M, Alfonso P, Irun P, Atutxa K, Acedo A, Barez A, Blanes M, Diaz-Morant V, Fernández-Galán MA, Franco R, Gil-Cortes C, Giner V, Ibañez A, … Leer más
Osteoblastic cell response on high-rough titanium coatings by cold spray
J Mater Sci Mater Med. 2018 Feb 1;29(3):19. doi: 10.1007/s10856-018-6026-8. Vilardell AM, Cinca N, Garcia-Giralt N, Dosta S, Cano IG, Nogués X, Guilemany JM. https://www.ncbi.nlm.nih.gov/pubmed/29392501
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D. Osteoporos Int. 2018 Feb;29(2):323-328. doi: 10.1007/s00198-017-4304-9. Epub 2017 Nov 22.